Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Title: Is the Combination of Screening Algorithms and Use of Hepatitis B Rapid Tests Useful in Optimizing the Screening and Prevention of Hepatitis B?      
available:
True
dateReleased:
01-10-2013
description:
With over 280 000 chronic carriers, 2,500 new annual cases and 1,300 deaths each year, hepatitis B is currently a frequent and potentially severe disease in France, despite efforts towards prevention and effective care. In terms of prevention, France has very low immunization coverage (27.7%) and a high percentage of people ignoring HBV status (55%), leading to a delay in care. This is partly explained by poor knowledge of hepatitis B infection in the general population and an underestimation of the health impact of hepatitis B by doctors and health officials. Until recently, there have been no national guidelines governing its implementation (which is variable depending on the structures where screening is performed) and an insufficient evaluation of screening practices. Thus, data on the severity of liver disease, indications for treatment of HBV-infected patients and data on the use of vaccination for nonimmunized people are scarce. Furthermore, while HIV rapid tests are beginning to be used more widely, particularly to address the issue of people who do not come back and collect their results and to better adapt "counselling", their usefulness to detect of hepatitis B virus has not been evaluated to date. The main objective of the Optiscreen B Study is to determine the benefit, if any, of using rapid tests as a screening tool to improve diagnosis, care and prevention of hepatitis B. Individuals risk of HBV-infection will be randomized into 2 groups, one group for which screening will be performed by usual serological test and a second group for which screening will be based on rapid tests. Centers will be selected to represent a diverse range of health centers whose aims include screening, prevention and/or vaccination.
privacy:
information not available
aggregation:
instance of dataset
ID:
NCT01767597
refinement:
curated
keywords:
rapid test
screening
ELISA
hepatitis B virus
access to care
dateModified:
10-21-2016
availability:
available
types:
clinical trial
ID:
Bottero J, Boyd A, Gozlan J, Carrat F, Lemoine M, Rougier H, Varsat B, Boo N, Charlois-Ou C, Collignon A, Cha O, Campa P, Dhotte P, Girard PM, Lacombe K. Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study. Eur J Gastroenterol Hepatol. 2016 Jun;28(6):633-9. doi: 10.1097/MEG.0000000000000620.
funders:
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
selectionCriteria:
Inclusion Criteria: - Born in a country of middle or high HBV endemicity - Parents born in a country of middle or high HBV endemicity - Travellers or residents from a country of middle or high HBV endemicity - Blood, organ, tissue, sperm, and/or ovary donners or candidate donners. - Health-care workers suspected of coming into direct contact with an HBV-infected individual and/or exposed to blood or any biological products from an HBV-infected individual - Close contact with HBsAg-positive individuals (living in the same household, sexual partner, sharing needles, etc.) - Individuals with accidental exposure to HBV - Individuals with multiple sexual partners - Men who have sex with men - Pregnant women - Hemodialysis - Individuals requiring immunosuppressive therapy - Individuals with persistently elevated transaminase levels - HIV-positive - Intravenous drug users Exclusion Criteria: - Age <18 years old - Not capable of providing informed consent - Already participated in a multi-center validation of HBV rapid tests - Having, in their possession, irrefutable results of a prior test for hepatitis B virus
studyGroups:
ELISA testing
Rapid testing
types:
Interventional
ID:
IMEA 38
accessURL: https://clinicaltrials.gov/ct2/show/results/NCT01767597
storedIn:
ClinicalTrial.gov
format:
HTML
accesstypes:
landing page
dateVerified:
20161001
authentication:
none
authorization:
none
creators:
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
homepage: https://clinicaltrials.gov
ID:
SCR:002309
name:
ClinicalTrials.gov

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on GitHub.